Nucleos(t)ide Analogue (NA)

DRUG2 trials

Sponsors

Ausper Biopharma Co., Ltd., AusperBio Therapeutics Inc.

Conditions

Chronic Hepatitis B InfectionHepatitis B, Chronic

Phase 1

A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants

RecruitingNCT07511218

Ausper Biopharma Co., Ltd.Chronic Hepatitis B Infection

Start: 2026-04-13End: 2028-06-30Target: 110Updated: 2026-07-21

Study of AHB-171 in Chronic Hepatitis B Participants

Not yet recruitingNCT07617194

AusperBio Therapeutics Inc.Hepatitis B, Chronic

Start: 2026-07-06End: 2028-08-14Target: 144Updated: 2026-06-01